Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery
Diseases of the Esophagus · 2024
DOI: 10.1093/dote/doae026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2024. Verfasst von Su Pei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophagectomy, Neoplasm Staging, Chemoradiotherapy, Adjuvant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Department of Education of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
To assess adjuvant treatment patterns on survival in patients with pT3N0M0 esophageal cancer who underwent esophagectomy without neoadjuvant chemoradiotherapy. Stage pT3N0M0 esophageal cancer patients were assessed between 2000 and 2020 from the Surveillance, Epidemiology, and End Results databases. Kaplan–Meier analysis was used to compare overall survival (OS) among various treatment patterns. We identified 445 patients: 252 (56.6%) received surgery alone, 85 (19.1%) received surgery+chemoradiotherapy, 80 (18.0%) underwent surgery+chemotherapy, and 28 (6.3%) received surgery+ radiotherapy. For squamous cell carcinoma, surgery+chemoradiotherapy ([hazard ratio] HR = 1.04, 95% confidence interval (CI): 0.65–1.66; P = 0.873), surgery+chemotherapy (HR = 0.72, 95% CI: 0.42–1.22; P = 0.221), and surgery+radiotherapy (HR = 1.33, 95% CI: 0.74–2.39; P = 0.341) had similar OS compared to surgery alone. For adenocarcinoma, surgery+chemoradiotherapy (HR = 0.51, 95% CI: 0.36–0.74; P < 0.001) and surgery+chemotherapy (HR = 0.61, 95% CI: 0.42–0.87; P = 0.006) had better OS compared to surgery alone. However, surgery+radiotherapy had a comparable OS (HR = 0.81, 95% CI: 0.44–1.49; P = 0.495).Adjuvant treatments did not improve survival in stage pT3N0M0 esophageal squamous cell carcinoma patients. In contrast, adjuvant chemoradiotherapy and chemotherapy were recommended for esophageal adenocarcinoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Förderung
- Department of Education of Guangxi Zhuang Autonomous Region
Zitieren
APA
Pei, S., Huang, J. Q., Liang, H. W., Liu, Y., Chen, L., Yu, B. B., Huang, W., & Pan, X. B. (2024). Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae026
Vancouver
Pei S, Huang JQ, Liang HW, Liu Y, Chen L, Yu BB, et al. Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery. Diseases of the Esophagus. 2024. doi:10.1093/dote/doae026
BibTeX
@article{Pei2024,
author = {Pei, Su and Huang, Jiang-Qiong and Liang, Huan-Wei and Liu, Yang and Chen, Long and Yu, Bin-Bin and Huang, Wei and Pan, Xin-Bin},
title = {Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery},
journal = {Diseases of the Esophagus},
year = {2024},
doi = {10.1093/dote/doae026}
}
EUVIMED